Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Hempdocon Jun 23, 2020 8:48pm
131 Views
Post# 31183766

The Erosion Of Science/Research...

The Erosion Of Science/Research...

for the betterment of society, or for the enrichment of Big Pharma & all of those who have their hands in Pharm's deep pockets (academicians, so-called independent experts, the MSM)? So many instances where HCQ is being intentionally maligned in the research/clinical trial world...sad reality.  Also, just because a study may be randomized/placebo-controlled/double-blinded doesn't make it valid, or even on point.  You can tailor any study to your (Big Pharma's) desired outcome...like practically overdosing HCQ cohorts in already hospitalized/critically ill/high-risk patients (many with cardiac disease/failure).  It's not too difficult to tarnish a drug if there's enough $ incentive.

One simply needs to keep his eye on legitimate studies that not only "properly dose", but also "properly test/utilize" HCQ as a "combination" drug (not monotherapy) in an "ambulatory" setting. "Early use" is key for any anti-viral in general...once you wait until someone is critically ill, oxygen-requiring, mechanically ventilated or in the ARD stage, the viral load is much too high & "any" anti-viral will show little to no benefit in terms of reducing mortality.  Unfortunately, too few studies exist looking at HCQ properly.  

https://healthimpactnews.com/2020/editors-of-the-lancet-and-the-new-england-journal-of-medicine-pharmaceutical-companies-are-so-financially-powerful-they-pressure-us-to-accept-papers/

Bullboard Posts